RNAC stock

Cartesian Therapeutics Inc. (RNAC) revenue is $452.0K

Cartesian Therapeutics Inc. (RNAC) revenue is $452.0K as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full RNAC research page for quote, filings, and the rest of the model. This satellite exists so “Cartesian Therapeutics Inc. revenue” can rank with the actual number, then send you to /stock/rnac.

Full RNAC analysis